Moderna’s stock rallies as settlement of a patent dispute clears vaccine pipeline

The deal would provide ‘certainty’ for Moderna’s vaccine portfolio.

Previous Article

Oil-production shutdowns loom as some Middle Eastern countries could run out of storage

Next Article

This stock-market correction signal just triggered for only the third time in seven years. Here’s the message for investors.

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *

81 − = 73
Powered by MathCaptcha

Subscribe to our Newsletter

Subscribe to our email newsletter to get the latest posts delivered right to your email.
Pure inspiration, zero spam ✨